Pulse Biosciences Inc PLSE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/30/24 EDT
7.37UNCH (UNCH)
Volume
8,282
Close
7.37UNCH (UNCH)
Volume
187,448
52 week range
3.78 - 13.62
Loading...
  • Open7.11
  • Day High7.77
  • Day Low7.07
  • Prev Close7.37
  • 52 Week High13.62
  • 52 Week High Date12/22/23
  • 52 Week Low3.78
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap407.011M
  • Shares Out55.23M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.73
  • YTD % Change-39.79

KEY STATS

  • Open7.11
  • Day High7.77
  • Day Low7.07
  • Prev Close7.37
  • 52 Week High13.62
  • 52 Week High Date12/22/23
  • 52 Week Low3.78
  • 52 Week Low Date10/26/23
  • Market Cap407.011M
  • Shares Out55.23M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.73
  • YTD % Change-39.79

RATIOS/PROFITABILITY

  • EPS (TTM)-0.89
  • P/E (TTM)-8.25
  • Fwd P/E (NTM)-11.17
  • EBITDA (TTM)-42.267M
  • ROE (TTM)-200.47%
  • Revenue (TTM)-
  • Gross Margin (TTM)-4,210.55%
  • Net Margin (TTM)-19,934.77%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pulse Biosciences Inc

 

Profile

MORE
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers....
Robert Duggan
Executive Chairman of the Board
Kevin Danahy
President, Chief Executive Officer
Darrin Uecker
Chief Technology Officer, Director
Address
3957 Point Eden Way
Hayward, CA
94545-3720
United States

Top Peers

SYMBOLLASTCHG%CHG
REPL
Replimune Group Inc
6.35UNCHUNCH
TRML
Tourmaline Bio Inc
15.83UNCHUNCH
BMEA
Biomea Fusion Inc
10.74UNCHUNCH
PEPG
PepGen Inc
12.28UNCHUNCH
LXRX
Lexicon Pharmaceuticals Inc
1.54UNCHUNCH